Epstein said he felt it more appropriate to be inserted after the 
first sentence of paragraph 184. 
Dr. Musgrave asked if Dr. Gottesman had wanted to add anything 
about requirements for biosafety signs. Dr. Gottesman said she 
didn't think it was relevant to this discussion. It was an issue 
possibly pertaining to the plant section of the proposal, and she 
would discuss it at that time. 
Mr. Mitchell repeated the motion to accept paragraphs 17, 21, 25, 
29, 32, 34, 37, 41, and 182 through 341, with an amendment to 
paragraph 285 to reduce the age mentioned therein from 18 to 16. 
Mr. Mitchell then asked for a vote on Dr. Walters' motion to call 
the question. The motion to cut off further debate passed by a 
vote of 19 in favor, none opposed, and no abstentions. 
The Chair then called for a vote on Dr. Gottesman' s motion. The 
motion was passed by a vote of 17 in favor, none opposed, and one 
abstention. 
VII. RECOGNITION OF RETIRING COMMITTEE MEMBERS. 
The Chair noted that there were several members of the committee 
who were serving at their final meeting. He noted also that 
Dr. Bernard Talbot, Deputy Director of the National Institute of 
Allergy and Infectious Diseases had moved to a new position at 
the NIH. He noted the key role Dr. Talbot had played in the work 
of the committee dating back to 1975, and he would be sorely 
missed. He extended both his own appreciation and that of the 
RAC to Dr. Talbot for his work on behalf of the RAC. A certifi- 
cate of appreciation would be sent to him. He also presented 
certificates of service to the RAC to Dr. Rapp, Dr. Pirone, Mrs. 
Witherby, and Dr. Walters and noted that certificates would be 
sent to Dr Sharpies and Dr. Bowman. 
Dr. Gartland then took the floor to mention that this would be 
Mr. Mitchell's final meeting as well. He thanked him for his 
many hours of untiring service to the RAC and to the NIH and 
presented him with a certificate signed by Dr. Wyngaarden for 
extraordinary service as Chair of the RAC. Mr. Mitchell 
responded by saying he had served as an advisor and consultant to 
many groups, but he felt privileged to have served on the RAC. 
He said it was, "a unique organization, bringing together so many 
fine minds and talents on such critical and tough issues." He 
thanked the group and said he looked forward to having an 
opportunity to see many of the members again in the future. 
Recombinant DNA Research, Volume 13 
[67] 
